New Advances Can Slow Alzheimers Progression: Facts For Pharmacists and Technicians
Tracking # 20-1358897
$25.99
There are no ratings for this course
What you'll learn
Following this course, course participants will be able to:
- Have a better understanding about biomarkers that enable early AD diagnosis, track disease progression, and assess therapeutic efficacy in clinical trials.
- Describe the role of plaques and tangles in Alzheimer’s disease.
- Have a better understanding about FDA approved blood tests to identify early onset AD.
- Comprehend and discuss FDA approved infusion treatments to slow AD's progression.
- Comprehend and discuss pros and cons of Kinsula and Leqembi.
Course overview
This 3-hour course examines many of the latest medical advances including: -Biomarkers that enable early diagnosis, track disease progression, and assess therapeutic efficacy in clinical trials; -FDA-cleared blood tests for identifying AD at early stages; -FDA approved infusion treatments to slow AD progression; -Pros and cons of new treatments; and -Additional topics being researched. These medical advances are making it possible for scientists, health care providers, patients, and loved ones to change their understanding of AD by learning about steps that can be taken that may slow its progression.
Subject areas
This course counts toward the state boards and subject areas below.
Florida Board of Pharmacy
Pharmacist
Registered Pharmacy Technician
Disclosure statements
Take it Here
- This course reports to CE Broker immediately upon completion.
- Complete all courses at your own pace online.
- Quality and enjoyable courses.
- Modern experience, accessible from any device.
- All courses affordably priced.